Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure. / Omar, Massar; Jensen, Jesper; Frederiksen, Peter H.; Videbæk, Lars; Poulsen, Mikael Kjær; Brønd, Jan Christian; Gustafsson, Finn; Borlaug, Barry A.; Schou, Morten; Møller, Jacob Eifer.

I: JACC: Heart Failure, Bind 9, Nr. 11, 2021, s. 824-835.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Omar, M, Jensen, J, Frederiksen, PH, Videbæk, L, Poulsen, MK, Brønd, JC, Gustafsson, F, Borlaug, BA, Schou, M & Møller, JE 2021, 'Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure', JACC: Heart Failure, bind 9, nr. 11, s. 824-835. https://doi.org/10.1016/j.jchf.2021.05.013

APA

Omar, M., Jensen, J., Frederiksen, P. H., Videbæk, L., Poulsen, M. K., Brønd, J. C., Gustafsson, F., Borlaug, B. A., Schou, M., & Møller, J. E. (2021). Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure. JACC: Heart Failure, 9(11), 824-835. https://doi.org/10.1016/j.jchf.2021.05.013

Vancouver

Omar M, Jensen J, Frederiksen PH, Videbæk L, Poulsen MK, Brønd JC o.a. Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure. JACC: Heart Failure. 2021;9(11):824-835. https://doi.org/10.1016/j.jchf.2021.05.013

Author

Omar, Massar ; Jensen, Jesper ; Frederiksen, Peter H. ; Videbæk, Lars ; Poulsen, Mikael Kjær ; Brønd, Jan Christian ; Gustafsson, Finn ; Borlaug, Barry A. ; Schou, Morten ; Møller, Jacob Eifer. / Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure. I: JACC: Heart Failure. 2021 ; Bind 9, Nr. 11. s. 824-835.

Bibtex

@article{ef6c2fec6df648ccb19abe7785b460a4,
title = "Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure",
abstract = "Objectives: This study examined the link between accelerometer recordings and cardiac pathophysiology measured with right heart cauterization at rest and with exercise in patients with HFrEF. Background: Patient-worn accelerometers are increasingly being used in patients with heart failure with reduced ejection fraction (HFrEF) to assess activity and serve as surrogate endpoints in heart failure trials. Methods: Physical average daily activity (PADA) and total average daily activity according to accelerometer units were assessed in 63 patients (mean age 58 ± 10 years; mean ejection fraction 26% ± 4%). Patients underwent hemodynamic exercise testing and accelerometry. Patients were divided according to PADA in PADALow and PADAHigh activity level groups based on median counts per minute of physical activity. Results: Patients in the PADALow group were older and more frequently treated with diuretics. At rest, the PADALow group was characterized by a lower cardiac index (2.2 ± 0.4 L/min/m2 vs 2.4 ± 0.4 L/min/m2; P = 0.01) and stroke volume (70 ± 19 mL vs 81 ± 17 mL; P = 0.02) but not pulmonary capillary wedge pressure (12 ± 5 mm Hg vs 11 ± 5 mm Hg; P = 0.3). The PADALow group reached a lower cardiac index (4.8 ± 1.7 L/min/m2 vs 6.6 ± 1.7 L/min/m2; P < 0.001) but not in pulmonary capillary wedge pressure (31 ± 12 mm Hg vs 27 ± 8 mm Hg; P = 0.2) at peak exercise. The attenuated increase was associated with an attenuated increase in stroke volume (94 ± 32 mL vs 121 ± 29 mL; P < 0.001) rather than a reduced increase in heart rate (42 ± 23 beats/min vs 52 ± 21 beats/min; P = 0.07). PADA and total average daily accelerometer units were associated with patient-reported functional impairment according to the Kansas City Cardiomyopathy Questionnaire but not with New York Heart Association functional class. Conclusions: Among stable ambulatory patients with HFrEF, lower daily activity is associated with poorer cardiac index reserve and reduced cardiac index during exercise. (Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction; NCT03198585)",
keywords = "accelerometer, exercise testing, hemodynamics, HFrEF, patient-centric outcome",
author = "Massar Omar and Jesper Jensen and Frederiksen, {Peter H.} and Lars Videb{\ae}k and Poulsen, {Mikael Kj{\ae}r} and Br{\o}nd, {Jan Christian} and Finn Gustafsson and Borlaug, {Barry A.} and Morten Schou and M{\o}ller, {Jacob Eifer}",
note = "Publisher Copyright: {\textcopyright} 2021 American College of Cardiology Foundation",
year = "2021",
doi = "10.1016/j.jchf.2021.05.013",
language = "English",
volume = "9",
pages = "824--835",
journal = "J A C C: Heart Failure",
issn = "2213-1779",
publisher = "Elsevier",
number = "11",

}

RIS

TY - JOUR

T1 - Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure

AU - Omar, Massar

AU - Jensen, Jesper

AU - Frederiksen, Peter H.

AU - Videbæk, Lars

AU - Poulsen, Mikael Kjær

AU - Brønd, Jan Christian

AU - Gustafsson, Finn

AU - Borlaug, Barry A.

AU - Schou, Morten

AU - Møller, Jacob Eifer

N1 - Publisher Copyright: © 2021 American College of Cardiology Foundation

PY - 2021

Y1 - 2021

N2 - Objectives: This study examined the link between accelerometer recordings and cardiac pathophysiology measured with right heart cauterization at rest and with exercise in patients with HFrEF. Background: Patient-worn accelerometers are increasingly being used in patients with heart failure with reduced ejection fraction (HFrEF) to assess activity and serve as surrogate endpoints in heart failure trials. Methods: Physical average daily activity (PADA) and total average daily activity according to accelerometer units were assessed in 63 patients (mean age 58 ± 10 years; mean ejection fraction 26% ± 4%). Patients underwent hemodynamic exercise testing and accelerometry. Patients were divided according to PADA in PADALow and PADAHigh activity level groups based on median counts per minute of physical activity. Results: Patients in the PADALow group were older and more frequently treated with diuretics. At rest, the PADALow group was characterized by a lower cardiac index (2.2 ± 0.4 L/min/m2 vs 2.4 ± 0.4 L/min/m2; P = 0.01) and stroke volume (70 ± 19 mL vs 81 ± 17 mL; P = 0.02) but not pulmonary capillary wedge pressure (12 ± 5 mm Hg vs 11 ± 5 mm Hg; P = 0.3). The PADALow group reached a lower cardiac index (4.8 ± 1.7 L/min/m2 vs 6.6 ± 1.7 L/min/m2; P < 0.001) but not in pulmonary capillary wedge pressure (31 ± 12 mm Hg vs 27 ± 8 mm Hg; P = 0.2) at peak exercise. The attenuated increase was associated with an attenuated increase in stroke volume (94 ± 32 mL vs 121 ± 29 mL; P < 0.001) rather than a reduced increase in heart rate (42 ± 23 beats/min vs 52 ± 21 beats/min; P = 0.07). PADA and total average daily accelerometer units were associated with patient-reported functional impairment according to the Kansas City Cardiomyopathy Questionnaire but not with New York Heart Association functional class. Conclusions: Among stable ambulatory patients with HFrEF, lower daily activity is associated with poorer cardiac index reserve and reduced cardiac index during exercise. (Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction; NCT03198585)

AB - Objectives: This study examined the link between accelerometer recordings and cardiac pathophysiology measured with right heart cauterization at rest and with exercise in patients with HFrEF. Background: Patient-worn accelerometers are increasingly being used in patients with heart failure with reduced ejection fraction (HFrEF) to assess activity and serve as surrogate endpoints in heart failure trials. Methods: Physical average daily activity (PADA) and total average daily activity according to accelerometer units were assessed in 63 patients (mean age 58 ± 10 years; mean ejection fraction 26% ± 4%). Patients underwent hemodynamic exercise testing and accelerometry. Patients were divided according to PADA in PADALow and PADAHigh activity level groups based on median counts per minute of physical activity. Results: Patients in the PADALow group were older and more frequently treated with diuretics. At rest, the PADALow group was characterized by a lower cardiac index (2.2 ± 0.4 L/min/m2 vs 2.4 ± 0.4 L/min/m2; P = 0.01) and stroke volume (70 ± 19 mL vs 81 ± 17 mL; P = 0.02) but not pulmonary capillary wedge pressure (12 ± 5 mm Hg vs 11 ± 5 mm Hg; P = 0.3). The PADALow group reached a lower cardiac index (4.8 ± 1.7 L/min/m2 vs 6.6 ± 1.7 L/min/m2; P < 0.001) but not in pulmonary capillary wedge pressure (31 ± 12 mm Hg vs 27 ± 8 mm Hg; P = 0.2) at peak exercise. The attenuated increase was associated with an attenuated increase in stroke volume (94 ± 32 mL vs 121 ± 29 mL; P < 0.001) rather than a reduced increase in heart rate (42 ± 23 beats/min vs 52 ± 21 beats/min; P = 0.07). PADA and total average daily accelerometer units were associated with patient-reported functional impairment according to the Kansas City Cardiomyopathy Questionnaire but not with New York Heart Association functional class. Conclusions: Among stable ambulatory patients with HFrEF, lower daily activity is associated with poorer cardiac index reserve and reduced cardiac index during exercise. (Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction; NCT03198585)

KW - accelerometer

KW - exercise testing

KW - hemodynamics

KW - HFrEF

KW - patient-centric outcome

U2 - 10.1016/j.jchf.2021.05.013

DO - 10.1016/j.jchf.2021.05.013

M3 - Journal article

C2 - 34509409

AN - SCOPUS:85117161453

VL - 9

SP - 824

EP - 835

JO - J A C C: Heart Failure

JF - J A C C: Heart Failure

SN - 2213-1779

IS - 11

ER -

ID: 284093573